Cover Image
市場調查報告書

心律管理的美國市場

U.S. Markets for Cardiac Rhythm Management

出版商 Medtech Insight 商品編碼 324808
出版日期 內容資訊 英文 118 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
心律管理的美國市場 U.S. Markets for Cardiac Rhythm Management
出版日期: 2015年02月24日 內容資訊: 英文 118 Pages
簡介

美國的心律管理設備 (CRM設備) 預計今後以2.9%的年複合成長率擴大,成長到約11億美元。診斷用CRM產品以4.8%,治療用CRM產品以2.7%的年複合成長率成長。

本報告提供美國的心律管理設備 市場相關調查、治療數、市場預測、各產品市場主要影響成長要素、美國的主要供應商的市場佔有率、銷售額預測、各產品市場主要供應商的產品系列分析,及可改變產品市場發展的創新技術等彙整資料,為您概述為以下內容。

摘要整理

第1章 心律不整疾病概要

  • 心臟、循環系統
  • 心臟傳導系統
  • 主要的心律不整疾病
    • 心搏過緩
    • 病竇症候群
    • 心臟區域
    • 頻拍
    • 心房纖維顫動
    • 心室顫動

第2章 美國的心律管理設備市場

  • 診斷用心律管理設備:市場分析
    • 心電圖記錄產品:市場分析
      • 產品數
      • 產品
      • 市場預測
      • 競爭分析
    • 電生理學產品:市場分析
  • 治療用心律管理設備:市場分析
    • 心臟再同步化治療產品:市場分析
      • 植入式心臟起搏系統
      • 一時性起搏系統
      • 治療數
      • 產品
      • 市場預測
      • 競爭分析
    • 體外電擊器:市場分析
    • 植入式心臟整流去顫器:市場分析
    • 心臟再同步化治療:市場分析
    • 心律不整燒灼手術

附錄:企業清單

目錄
Product Code: A233

Cardiac rhythm management (CRM) devices, which encompasses diagnostic and therapeutic systems, represents a well-established market that is still seeing innovation in some of the segments that compose it. Over the forecast period covered in this report, the estimated value of the U.S. market for CRM devices is expected to grow by approximately $1.1 billion at compound annual growth rate (CAGR) of 2.9%; of this holistic market, diagnostic CRM products are forecasted to grow at a CAGR of 4.8%, while therapeutic CRM products will grow at a CAGR of 2.7%.

Contents of this report include:

  • procedure and market forecasts for the years 2014 to 2019;
  • key factors influencing the growth of individual product markets;
  • estimated market shares and sales among major U.S. suppliers;
  • major supplier product portfolio analysis in individual product markets; and,
  • innovative technology that could potentially change the way product markets develop.

The scope of the analysis of this report covers diagnostic and therapeutic modalities used in the management of cardiac rhythm disorders. Diagnostic modalities covered in this report include electrocardiography (ECG) systems and electrophysiology (EP) catheters. Therapeutic modalities discussed in this report include ablation catheters (surgical and transcatheter), cardiac resynchronization therapy (CRT) systems, external defibrillators, implantable cardioverter defibrillators (ICDs), and pacemakers.

Table of Contents

EXECUTIVE SUMMARY

  • i. Methodology
  • Exhibit ES-1: 2014, U.S. Cardiac Rhythm Management Market, Share by Products

1. CARDIAC RHYTHM DISORDERS OVERVIEW

  • 1.1. The Heart and Circulatory System
  • 1.2. The Cardiac Conduction System
  • 1.3. Selected Cardiac Rhythm Disorders
    • 1.3.1. Bradycardia
    • 1.3.2. Sick Sinus Syndrome
    • 1.3.3. Heart Block
    • 1.3.4. Tachycardia
    • 1.3.5. Atrial Fibrillation
    • 1.3.6. Ventricular Fibrillation
  • Exhibit 1-1: Cross-Section Diagrams of the Heart Illustrating the Direction of Blood Flow during Diastole and Systole
  • Exhibit 1-2: Cross-Section Diagrams of the Heart Valve Positions during Diastole and Systole
  • Exhibit 1-3: Diagram of Selected Coronary Arteries
  • Exhibit 1-4: Diagram of Cardiac Conduction System
  • Exhibit 1-5: Cardiac Arrhythmias, Selected Statistics

2. U.S. MARKETS FOR CARDIAC RHYTHM MANAGEMENT DEVICES

  • 2.1. Diagnostic Cardiac Rhythm Management Devices, Market Analysis
    • 2.1.1. Electrocardiography Products, Market Analysis
      • 2.1.1.1. Procedure Volumes
      • 2.1.1.2. Products
      • 2.1.1.3. Market Forecast
      • 2.1.1.4. Competitive Analysis
    • 2.1.2. Electrophysiology Products, Market Analysis
      • 2.1.2.1. Procedure Volumes
      • 2.1.2.2. Products
      • 2.1.2.3. Market Forecast
      • 2.1.2.4. Competitive Analysis
  • 2.2. Therapeutic Cardiac Rhythm Management Devices, Market Analysis
    • 2.2.1. Cardiac Resynchronization Therapy Products, Market Analysis
      • 2.2.1.1. Implantable Cardiac Pacing Systems
      • 2.2.1.2. Temporary Pacing Systems
      • 2.2.1.3. Procedure Volumes
      • 2.2.1.4. Products
      • 2.2.1.5. Market Forecast
      • 2.2.1.6. Competitive Analysis
    • 2.2.2. External Defibrillator Products, Market Analysis
      • 2.2.2.1. Placement Volumes
      • 2.2.2.2. Products
      • 2.2.2.3. Market Forecast
      • 2.2.2.4. Competitive Analysis
    • 2.2.3. Implantable Cardioverter Defibrillator Products, Market Analysis
      • 2.2.3.1. Procedure Volumes
      • 2.2.3.2. Products
      • 2.2.3.3. Market Forecast
      • 2.2.3.4. Competitive Analysis
    • 2.2.4. Cardiac Resynchronization Therapy, Market Analysis
      • 2.2.4.1. Cardiac Resynchronization Therapy Systems
      • 2.2.4.1. Procedure Volumes
      • 2.2.4.2. Products
      • 2.2.4.3. Market Forecast
      • 2.2.4.4. Competitive Analysis
    • 2.2.5. Arrhythmia Ablation
      • 2.2.5.1. Transcatheter Arrhythmia Ablation
      • 2.2.5.2. Transcatheter Ablation of Atrial Fibrillation
      • 2.2.5.3. Direct Energy-Based Surgical Ablation of Atrial Fibrillation
      • 2.2.5.4. Procedure Volumes
      • 2.2.5.5. Products
      • 2.2.5.6. Market Forecast
      • 2.2.5.7. Competitive Analysis
  • Exhibit 2-1: Cardiac Rhythm Management, Combined Procedure Volumes Forecast, 2014-2019
  • Exhibit 2-2: Cardiac Rhythm Management Products, Combined Market Forecast, 2014-2019
  • Exhibit 2-3: Normal Electrocardiogram Tracing
  • Exhibit 2-4: Electrocardiography, Procedure Volumes Forecast, 2014-2019
  • Exhibit 2-5: Electrocardiography Products, Market Forecast, 2014-2019
  • Exhibit 2-6: 2014, Electrocardiography Products Market, Share by Supplier
  • Exhibit 2-7: Diagnostic Electrophysiology, Procedure Volumes Forecast, 2014-2019
  • Exhibit 2-8: Electrophysiology Systems, Market Forecast, 2014-2019
  • Exhibit 2-9: 2014, Electrophysiology Products Market, Share by Supplier
  • Exhibit 2-10: NBG Code for Implantable Pacemaker Systems
  • Exhibit 2-11: Cardiac Pacemaker Implantation, Procedure Volumes Forecast, 2014-2019
  • Exhibit 2-12: Pacemaker Products, Market Forecast, 2014-2019
  • Exhibit 2-13: 2014, Pacemaker Products Market, Share by Supplier
  • Exhibit 2-14: External Defibrillation, Placement Volumes Forecast, 2014-2019
  • Exhibit 2-15: External Defibrillator Products, Market Forecast, 2014-2019
  • Exhibit 2-16: 2014, External Defibrillator Products Market, Share by Supplier
  • Exhibit 2-17: NBD Code and Labeling for Implantable Cardioverter Defibrillators
  • Exhibit 2-18: Implantable Cardioverter Defibrillator Implantation, Procedure Volumes Forecast, 2014-2019
  • Exhibit 2-19: Implantable Cardioverter Defibrillator Products, Market Forecast, 2014-2019
  • Exhibit 2-20: 2014, Implantable Cardioverter Defibrillator Products Market, Share by Supplier
  • Exhibit 2-21: Cardiac Resynchronization Therapy, Procedure Volumes Forecast, 2014-2019
  • Exhibit 2-22: Cardiac Resynchronization Therapy Products, Market Forecast, 2014-2019
  • Exhibit 2-23: 2014, Cardiac Resynchronization Therapy Products Market, Share by Supplier
  • Exhibit 2-24: Cardiac Ablation, Procedure Volumes Forecast, 2014-2019
  • Exhibit 2-25: Cardiac Ablation Products, Market Forecast, 2014-2019
  • Exhibit 2-26: 2014, Transcatheter Ablation Systems Products Market, Share by Supplier
  • Exhibit 2-27: 2014, Surgical Ablation Systems Products Market, Share by Supplier

APPENDIX: COMPANY LISTING

Back to Top